This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Resistance and Aerobic Exercise With Nutritional Supplementation in Men and Women (S-017)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Wayne Campbell, Purdue University
ClinicalTrials.gov Identifier:
NCT00812409
First received: December 18, 2008
Last updated: January 16, 2013
Last verified: January 2013
  Purpose
The purpose of this study is to identify the influence of resistance and aerobic exercise with different nutritional supplements in middle-aged men and women on various physiological measures. Throughout the study, the investigators examine body composition, body weight, food intake, fitness level, metabolism, and blood hormones.

Condition Intervention
Obesity Dietary Supplement: Whey protein supplementation with exercise Other: Non protein supplementation with exercise (control)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator)
Primary Purpose: Prevention
Official Title: Resistance and Aerobic Exercise With Nutritional Supplementation in Men and Women

Resource links provided by NLM:


Further study details as provided by Wayne Campbell, Purdue University:

Primary Outcome Measures:
  • Influence of resistance and aerobic exercise and whey protein on body weight and body composition (fat mass and fat free mass). [ Time Frame: 36 weeks ]

Secondary Outcome Measures:
  • Influence of resistance and aerobic exercise and whey protein on dietary and macronutrient intakes, insulin-mediated glucose metabolism, physical fitness and markers of metabolic and cardiovascular health. [ Time Frame: 36 weeks ]

Enrollment: 580
Study Start Date: April 2007
Study Completion Date: September 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Control group: non-protein supplement with resistance and aerobic exercise.
Other: Non protein supplementation with exercise (control)
Non protein supplementation with resistance and aerobic exercise.
Experimental: 2
Low protein supplement with resistance and aerobic exercise.
Dietary Supplement: Whey protein supplementation with exercise
Whey protein supplementation with resistance and aerobic exercise.
Experimental: 3
Moderate protein supplement with resistance and aerobic exercise.
Dietary Supplement: Whey protein supplementation with exercise
Whey protein supplementation with resistance and aerobic exercise.
Experimental: 4
High protein supplement with resistance and aerobic exercise.
Dietary Supplement: Whey protein supplementation with exercise
Whey protein supplementation with resistance and aerobic exercise.

  Eligibility

Ages Eligible for Study:   35 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • men and women age 35-65 yr
  • body weight <300 lbs (136 kg)
  • body mass index between 28 kg/m2 and 35 kg/m2
  • fasting glucose <110 mg/dL
  • blood pressure <160/100 mm Hg
  • plasma total cholesterol <260 mg/dL
  • LDL-cholesterol <160 mg/dL
  • triacylglycerol <400 mg/dL
  • not currently or previously following a weight loss diet or other special/non-balanced diet (in the past 6 months)
  • <1 hour/week of habitual aerobic exercise training and no resistance
  • exercise training (in the past 6 months)

Exclusion Criteria:

  • men and women age < 35 yr or >65 yr
  • body weight >300 lbs (136 kg)
  • body mass index between <28 kg/m2 or >35 kg/m2
  • fasting glucose >110 mg/dL
  • blood pressure >160/100 mm Hg
  • plasma total cholesterol >260 mg/dL
  • LDL-cholesterol >160 mg/dL
  • triacylglycerol >400 mg/dL
  • currently or previously following a weight loss diet or other special/non- balanced diet (in the past 6 months)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00812409

Locations
United States, Indiana
Purdue University
West Lafayette, Indiana, United States, 47907
Sponsors and Collaborators
Purdue University
Investigators
Principal Investigator: Wayne W Campbell, Ph.D. Purdue University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Wayne Campbell, Wayne Campbell, Ph.D., Purdue University
ClinicalTrials.gov Identifier: NCT00812409     History of Changes
Other Study ID Numbers: 0611004694
07053552
Study First Received: December 18, 2008
Last Updated: January 16, 2013

Keywords provided by Wayne Campbell, Purdue University:
Measuring markers of metabolic syndrome in overweight and obese adults.

ClinicalTrials.gov processed this record on June 28, 2017